ÂÜÀòÂÒÂ×

Regina Bis, Ph.D. has extensive work experience in biopharmaceutical companies and academic research. Regina is currently a Principal Scientist at KBI Biopharma, where they are responsible for leading fermentation processes in early-phase development. Their roles include process evaluation, optimization, and transfer to cGMP manufacturing. Regina also designs and executes experiments, interprets data, and recommends process adjustments. Prior to this, Dr. Bis held positions as a Senior Scientist, Process Development Scientist II, and Process Development Scientist I at KBI Biopharma. Regina also has experience as a CMC/Regulatory Compliance Specialist at the same company.

Prior to their industry work, Dr. Bis completed their Ph.D. at the University of Colorado Health Sciences Center. Their research focused on studying the biophysical effects of antimicrobial preservatives on protein stability and aggregation. Regina demonstrated a causal link between local protein unfolding and aggregation in the presence of preservatives. Additionally, they independently developed a purification scheme for interferon alpha-2a.

Regina Bis, Ph.D. obtained their Bachelor's degree in Chemical Engineering from the Colorado School of Mines in 2007. Regina then pursued their Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus from 2007 to 2014. Prior to that, they attended Mullen from 1999 to 2003, but their degree and field of study there are unknown.